Moreover, we found that PRAME overexpression in breast cancer cells dampens peripheral blood lymphocyte activation and cancer cell killing, concomitant with decreased levels of soluble pro‐inflammatory immune mediators and increased immune checkpoint expression. Here, PRAME is linked to breast carcinoma.